ALBUQUERQUE ― New Mexico Attorney General Hector Balderas has announced a new initiative by his office to combat the opioid abuse and addiction crisis in New Mexico.
Project OPEN: Opioid Prevention & Education Network will kick off by hosting an Opioid Abuse Training Jan. 11 in Albuquerque. The training, presented in conjunction with the National Association of Attorneys General, is free and will expose attorneys, policy advisors, investigators, healthcare professionals, consumer advocates and others to the impact and results of opioid abuse on New Mexico communities. It is intended to enhance the participants’ knowledge and understanding of opioid addiction and the countless issues involved.
“We can no longer allow opioid abuse and addiction to destroy New Mexico families and the future of our youth,” Balderas said. “I created Project OPEN in order to combat the opioid crisis in our state, and our first action will be training New Mexicans who are on the frontlines of this fight at our free Opioid Abuse Training. I encourage advocates, law enforcement officials, healthcare professionals and policy makers from all corners of New Mexico to attend this training so we can work together to make our families safer and healthier.”
Topics at the training include the following: Overview of Opioid Abuse Issues, Treatment Options and Issues, Protecting Consumers, Opioids and Dealing with Fraud, and Court Involvement and Beyond. Attorney General Balderas will present at the training in addition to experts from the Drug Enforcement Administration, Healing Addiction in our Community, National Association of Attorneys General, New Mexico Department of Health, New Mexico Office of the Attorney General, and the Ohio Office of the Attorney General. Dr. Theodore Parran and former First Judicial District Attorney Angela Spence Pacheco will also present.
To register for the free training, call Tamarra Howard with the New Mexico Office of the Attorney General at 505.717.3506 or email email@example.com.
This training is made possible by a grant from the State Attorney General Consumer and Prescriber Education Grant Program, which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin.